サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ウシ胎児血清市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2021年～2031年）
市場調査レポート
商品コード
1081012

ウシ胎児血清市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2021年～2031年）

Fetal Bovine Serum Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 340 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ウシ胎児血清市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2021年～2031年）
出版日: 2022年04月28日
発行: Transparency Market Research
ページ情報: 英文 340 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要
当レポートでは、世界のウシ胎児血清市場について調査し、市場の概要とともに、2021年～2031年の予測、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー：世界のウシ胎児血清市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界のウシ胎児血清市場の分析と予測、2017年～2031年
  • ポーターのファイブフォース分析

第5章 重要な洞察

第6章 世界のウシ胎児血清市場の分析と予測、用途別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、用途別、2017年～2031年
    • 創薬
    • 細胞培養用培地
    • 体外受精
    • ヒトおよび動物のワクチン生産
    • 診断
    • その他
  • 市場の魅力分析

第7章 世界のウシ胎児血清市場の分析と予測、エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、エンドユーザー別、2017～2031年
    • 研究・学術機関
    • 産業（医薬品、バイオテクノロジーなど）
    • ヘルスケア施設
  • 市場の魅力分析

第8章 世界のウシ胎児血清市場の分析と予測、地域別

  • 主な調査結果
  • 市場価値予測、地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析

第9章 北米のウシ胎児血清市場の分析と予測

第10章 欧州のウシ胎児血清市場の分析と予測

第11章 アジア太平洋のウシ胎児血清市場の分析と予測

第12章 ラテンアメリカのウシ胎児血清市場の分析と予測

第13章 中東・アフリカのウシ胎児血清市場の分析と予測

第14章 競合情勢

  • 市場参入企業-競合マトリクス
  • 市場シェア分析、企業別、2020年
  • 企業プロファイル
    • ANZCO Foods(Bovogen Biologicals Pvt. Ltd.)
    • ATCC
    • Bio-techne(Atlanta Biologicals, Inc.)
    • Captivate Bio
    • Danaher(Cytiva)
    • HiMedia Laboratories
    • Merck KGaA
    • Pan Biotech GmbH
    • Rocky Mountain Biologicals
    • TCS Biosciences Ltd.
    • Thermo Fisher Scientific Inc.
    • Zen-Bio, Inc.
図表

List of Tables

  • Table 01: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 02: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 05: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 06: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 07: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 09: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 18: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 02: Global Fetal Bovine Serum Market Value Share (%), by Region, 2020
  • Figure 03: Global Fetal Bovine Serum Market Value Share (%), by Application, 2020
  • Figure 04: Global Fetal Bovine Serum Market Value Share (%), by End-user, 2020
  • Figure 05: Global Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 06: Global Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 07: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Drug Discovery, 2017-2031
  • Figure 08: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Cell Media Culture, 2017-2031
  • Figure 09: Global Fetal Bovine Serum Market Revenue (US$ Mn), by In Vitro Fertilization, 2017-2031
  • Figure 10: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Human & Animal Vaccine Production, 2017-2031
  • Figure 11: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Diagnostics, 2017-2031
  • Figure 12: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 13: Global Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 14: Global Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 15: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Research & Academic Institutes, 2017-2031
  • Figure 16: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Industry, 2017-2031
  • Figure 17: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Healthcare Facilities, 2017-2031
  • Figure 18: Global Fetal Bovine Serum Market Value Share Analysis
  • Figure 19: Global Fetal Bovine Serum Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 20: North America Fetal Bovine Serum Market Value Share Analysis, by Country, 2020 and 2031
  • Figure 21: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 22: North America Fetal Bovine Serum Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 23: North America Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 24: North America Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 25: Europe Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 20201-2031
  • Figure 26: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 27: Europe Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 28: Europe Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 29: Europe Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 30: Europe Fetal Bovine Serum Market Attractiveness Index Analysis, by End-user, 2021-2031
  • Figure 31: Asia Pacific Fetal Bovine Serum Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 32: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 33: Asia Pacific Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 34: Asia Pacific Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 35: Asia Pacific Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 36: Asia Pacific Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 37: Asia Pacific Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 38: Latin America Fetal Bovine Serum Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 39: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 40: Latin America Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 41: Latin America Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 42: Latin America Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 43: Latin America Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 44: Latin America Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 45: Middle East & Africa Fetal Bovine Serum Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 46: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 47: Middle East & Africa Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 48: Middle East & Africa Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 49: Middle East & Africa Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 50: Middle East & Africa Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 51: Middle East & Africa Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021-2031
目次
Product Code: TMRGL20606

Fetal Bovine Serum Market - Scope of Report

TMR's report on the global fetal bovine serum market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global fetal bovine serum market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global fetal bovine serum market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the fetal bovine serum market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global fetal bovine serum market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global fetal bovine serum market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global fetal bovine serum market.

The report delves into the competitive landscape of the global fetal bovine serum market. Key players operating in the global fetal bovine serum market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global fetal bovine serum market profiled in this report.

Key Questions Answered in Fetal Bovine Serum Market Report

What will be the sales/revenue generated by fetal bovine serum across all regions during the forecast period?

What are the opportunities in the global fetal bovine serum market?

What are the major drivers, restraints, opportunities, and threats in the market?

Which regional market is set to expand at the fastest CAGR during the forecast period?

Which application is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?

What is the market position of different companies operating in the global market?

Fetal Bovine Serum Market - Research Objectives and Research Approach

The comprehensive report on the global fetal bovine serum market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global fetal bovine serum market in terms of application, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global fetal bovine serum market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Fetal Bovine Serum Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Application Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Fetal Bovine Serum Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
    • 4.4.2. Market Volume/Unit Shipments Projections
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
  • 5.2. Pipeline Analysis
  • 5.3. Regulatory scenario, by Region/Globally
  • 5.4. Covid-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Fetal Bovine Serum Market Analysis and Forecast, by Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Application, 2017-2031
    • 6.3.1. Drug Discovery
    • 6.3.2. Cell Media Culture
    • 6.3.3. In Vitro Fertilization
    • 6.3.4. Human & Animal Vaccine Production
    • 6.3.5. Diagnostics
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Application

7. Global Fetal Bovine Serum Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Research & Academic Institutes
    • 7.3.2. Industry (pharma, biotech, etc.)
    • 7.3.3. Healthcare Facilities
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Fetal Bovine Serum Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Fetal Bovine Serum Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Application, 2017-2031
    • 9.2.1. Drug Discovery
    • 9.2.2. Cell Media Culture
    • 9.2.3. In Vitro Fertilization
    • 9.2.4. Human & Animal Vaccine Production
    • 9.2.5. Diagnostics
    • 9.2.6. Others
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Research & Academic Institutes
    • 9.3.2. Industry (pharma, biotech, etc.)
    • 9.3.3. Healthcare Facilities
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Application
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Fetal Bovine Serum Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Application, 2017-2031
    • 10.2.1. Drug Discovery
    • 10.2.2. Cell Media Culture
    • 10.2.3. In Vitro Fertilization
    • 10.2.4. Human & Animal Vaccine Production
    • 10.2.5. Diagnostics
    • 10.2.6. Others
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Research & Academic Institutes
    • 10.3.2. Industry (pharma, biotech, etc.)
    • 10.3.3. Healthcare Facilities
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Application
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Fetal Bovine Serum Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Application, 2017-2031
    • 11.2.1. Drug Discovery
    • 11.2.2. Cell Media Culture
    • 11.2.3. In Vitro Fertilization
    • 11.2.4. Human & Animal Vaccine Production
    • 11.2.5. Diagnostics
    • 11.2.6. Others
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Research & Academic Institutes
    • 11.3.2. Industry (pharma, biotech, etc.)
    • 11.3.3. Healthcare Facilities
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Application
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Fetal Bovine Serum Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Application, 2017-2031
    • 12.2.1. Drug Discovery
    • 12.2.2. Cell Media Culture
    • 12.2.3. In Vitro Fertilization
    • 12.2.4. Human & Animal Vaccine Production
    • 12.2.5. Diagnostics
    • 12.2.6. Others
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Research & Academic Institutes
    • 12.3.2. Industry (pharma, biotech, etc.)
    • 12.3.3. Healthcare Facilities
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Application
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Fetal Bovine Serum Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Application, 2017-2031
    • 13.2.1. Drug Discovery
    • 13.2.2. Cell Media Culture
    • 13.2.3. In Vitro Fertilization
    • 13.2.4. Human & Animal Vaccine Production
    • 13.2.5. Diagnostics
    • 13.2.6. Others
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Research & Academic Institutes
    • 13.3.2. Industry (pharma, biotech, etc.)
    • 13.3.3. Healthcare Facilities
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Application
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix
  • 14.2. Market Share Analysis, by Company, 2020
  • 14.3. Company Profiles
    • 14.3.1. ANZCO Foods (Bovogen Biologicals Pvt. Ltd.)
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Business Strategies
      • 14.3.1.5. Recent Developments
    • 14.3.2. ATCC
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Business Strategies
      • 14.3.2.5. Recent Developments
    • 14.3.3. Bio-techne (Atlanta Biologicals, Inc.)
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Business Strategies
      • 14.3.3.5. Recent Developments
    • 14.3.4. Captivate Bio
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Business Strategies
      • 14.3.4.5. Recent Developments
    • 14.3.5. Danaher (Cytiva)
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Business Strategies
      • 14.3.5.5. Recent Developments
    • 14.3.6. HiMedia Laboratories
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Business Strategies
      • 14.3.6.5. Recent Developments
    • 14.3.7. Merck KGaA
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Business Strategies
      • 14.3.7.5. Recent Developments
    • 14.3.8. Pan Biotech GmbH
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Business Strategies
      • 14.3.8.5. Recent Developments
    • 14.3.9. Rocky Mountain Biologicals
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Business Strategies
      • 14.3.9.5. Recent Developments
    • 14.3.10. TCS Biosciences Ltd.
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. Business Strategies
      • 14.3.10.5. Recent Developments
    • 14.3.11. Thermo Fisher Scientific Inc.
      • 14.3.11.1. Company Overview
      • 14.3.11.2. Financial Overview
      • 14.3.11.3. Product Portfolio
      • 14.3.11.4. Business Strategies
      • 14.3.11.5. Recent Developments
    • 14.3.12. Zen-Bio, Inc.
      • 14.3.12.1. Company Overview
      • 14.3.12.2. Financial Overview
      • 14.3.12.3. Product Portfolio
      • 14.3.12.4. Business Strategies
      • 14.3.12.5. Recent Developments